Results 141 to 150 of about 28,931 (239)

Can chemotherapy be omitted for patients with N0 or N1 endocrine-sensitive breast cancer treated with gonadotropin-releasing hormone agonist and tamoxifen? [PDF]

Ann Surg Treat Res, 2023
Lee J, Park CS, Oh JH, Park IC, Seong MK, Noh WC, Kim HA.   +6 more
europepmc   +1 more source

Modified cytoskeletal and extracellular matrix composition in the canine testis after long-acting gonadotropin-releasing hormone agonist deslorelin treatment. [PDF]

Andrology
Gram A, Abay M, Gram DY, Liman N, Müller L, Balogh O.   +5 more
europepmc   +1 more source

Adult height in girls with central precocious puberty without gonadotropin-releasing hormone agonist treatment: a retrospective case-control study. [PDF]

J Yeungnam Med Sci, 2023
Jang HJ, Kwak MJ, Kim YM, Choi SH, Park KH, Yoo HW, Park SJ, Jo YH, Jo HY.   +8 more
europepmc   +1 more source

Comparison of the effect of gonadotropin-releasing hormone agonist dosage in girls with central precocious puberty. [PDF]

Ann Pediatr Endocrinol Metab, 2023
Jang S, Kim SJ, Lee M, Lee HI, Kwon A, Suh J, Song K, Chae HW, Kim HS.   +8 more
europepmc   +1 more source

Association of GnRH Agonist Pretreatment with Reproductive Outcomes in Women ≥35 years with Diminished Ovarian Reserve Undergoing Frozen Embryo Transfer: A Large Retrospective Cohort Study

International Journal of Women's Health
Yueping Zhou, Zhiqi Liao, Yaxin Guo Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of ChinaCorrespondence: Yaxin Guo, Reproductive Medicine Center, Tongji ...
Zhou Y, Liao Z, Guo Y
doaj  

Long-term outcomes of gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty. [PDF]

Ann Pediatr Endocrinol Metab
Hwangbo J, Kang E, Nam HK, Rhie YJ, Lee KH.   +4 more
europepmc   +1 more source

Pregnancy outcome in long- versus short-acting gonadotropin-releasing hormone agonist cycles in participants with normal ovarian reserve: An RCT. [PDF]

Int J Reprod Biomed, 2023
Kabodmehri R, Ghanami Gashti N, Raoufi A, Mehrafza M, Nikpouri Z, Hosseinzadeh E, Hosseini A.   +6 more
europepmc   +1 more source

The Double-Edged Nature of the Gonadotropin-Releasing Hormone Agonist (GnRHa) Long Protocol: A Case of Paradoxical Ovarian Hyperstimulation During the Expected Downregulation Phase. [PDF]

J Clin Med
Nádasdi B, Kovács P, Csajbók ÉA, Wellinger K, Vágvölgyi A, Zádori J.   +5 more
europepmc   +1 more source

Oncologic efficacy of gonadotropin-releasing hormone agonist in hormone receptor-positive very young breast cancer patients treated with neoadjuvant chemotherapy. [PDF]

World J Clin Cases, 2023
Choi HJ, Lee JH, Jung CS, Ryu JM, Chae BJ, Lee SK, Yu JH, Kim SW, Nam SJ, Lee JE, Jung YJ, Kim HY.   +11 more
europepmc   +1 more source

Optimal timing for triggering oocyte maturation during in vitro fertilization cycles varies between gonadotropin-releasing hormone agonist and human chorionic gonadotropin use. [PDF]

F S Rep
Enatsu N, Furuhashi K, Otsuki J, Enatsu K, Okamoto E, Kokeguchi S, Shiotani M.   +6 more
europepmc   +1 more source